Daniel M Musher

Summary

Country: USA

Publications

  1. doi request reprint How effective is vaccination in preventing pneumococcal disease?
    Daniel M Musher
    Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Infect Dis Clin North Am 27:229-41. 2013
  2. doi request reprint Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
    Daniel M Musher
    Michael E DeBakey VA Medical Center, Houston, Texas, USA
    J Infect Dis 201:516-24. 2010
  3. doi request reprint Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
    Daniel M Musher
    Michael E DeBakey VA Medical Center, Houston, TX, USA
    Hum Vaccin 7:919-28. 2011
  4. ncbi request reprint Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus
    Anjum S Kaka
    Section of Infectious Diseases, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 58:680-3. 2006
  5. doi request reprint The association between Staphylococcus aureus bacteremia and acute myocardial infarction
    Vicente F Corrales-Medina
    Michael E DeBakey VA Medical Center, Houston, Texas 77030, USA
    Scand J Infect Dis 41:511-4. 2009
  6. doi request reprint Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes
    Vicente F Corrales-Medina
    Department of Medicine, Baylor College of Medicine, Houston, Texas, USA vfmedina bcm edu
    Medicine (Baltimore) 88:154-9. 2009
  7. ncbi request reprint Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis
    Richard M Cadle
    Michael E DeBakey Veterans Affairs Medical Center MEDVAMC, Houston, TX 77030, USA
    Am J Health Syst Pharm 64:2359-63. 2007
  8. ncbi request reprint Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 59:705-10. 2007
  9. ncbi request reprint Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection
    Blanca E Gonzalez
    Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA
    Infect Control Hosp Epidemiol 27:1051-6. 2006
  10. pmc Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
    Daniel M Musher
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    J Infect Dis 198:1019-27. 2008

Detail Information

Publications50

  1. doi request reprint How effective is vaccination in preventing pneumococcal disease?
    Daniel M Musher
    Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Infect Dis Clin North Am 27:229-41. 2013
    ..Based on these observations, the CDC has now recommended that immunocompromized adults receive PCV13 followed 8 weeks later by PPV23...
  2. doi request reprint Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
    Daniel M Musher
    Michael E DeBakey VA Medical Center, Houston, Texas, USA
    J Infect Dis 201:516-24. 2010
    ..This study assessed antibody levels for 5 years after primary vaccination or revaccination with 23-valent pneumococcal polysaccharide vaccine (PN23)...
  3. doi request reprint Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
    Daniel M Musher
    Michael E DeBakey VA Medical Center, Houston, TX, USA
    Hum Vaccin 7:919-28. 2011
    ..Immunogenicity is preserved after multiple PN23 doses without evidence of a lower than expected immune response (i.e., without hyporesponsiveness)...
  4. ncbi request reprint Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus
    Anjum S Kaka
    Section of Infectious Diseases, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 58:680-3. 2006
    ....
  5. doi request reprint The association between Staphylococcus aureus bacteremia and acute myocardial infarction
    Vicente F Corrales-Medina
    Michael E DeBakey VA Medical Center, Houston, Texas 77030, USA
    Scand J Infect Dis 41:511-4. 2009
    ..SAB increased the risk for MI 35-fold in the 2 d after recognition of this infection (IRR = 35.3; CI 16.7-74.7)...
  6. doi request reprint Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes
    Vicente F Corrales-Medina
    Department of Medicine, Baylor College of Medicine, Houston, Texas, USA vfmedina bcm edu
    Medicine (Baltimore) 88:154-9. 2009
    ..6; 95% CI, 24.5-92.5). The characteristics and strength of these associations suggest a causal role for the acute infection in this relationship...
  7. ncbi request reprint Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis
    Richard M Cadle
    Michael E DeBakey Veterans Affairs Medical Center MEDVAMC, Houston, TX 77030, USA
    Am J Health Syst Pharm 64:2359-63. 2007
    ..difficile colitis, and recurrence of the disease in the 90 days after symptoms resolved. Outcomes of therapy were classified as cures, treatment failures, or disease recurrences...
  8. ncbi request reprint Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 59:705-10. 2007
    ..We have recently shown that nitazoxanide is as effective as metronidazole in initial therapy for C. difficile colitis. We hypothesized that this drug might be effective in treating patients who fail therapy with metronidazole...
  9. ncbi request reprint Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection
    Blanca E Gonzalez
    Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA
    Infect Control Hosp Epidemiol 27:1051-6. 2006
    ..This study examines the hypothesis that community-associated MRSA (CA-MRSA) strains now cause serious infections in hospitalized patients...
  10. pmc Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
    Daniel M Musher
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    J Infect Dis 198:1019-27. 2008
    ..We studied PPV, protein-conjugate pneumococcal vaccine (PCV), and immunologic "priming" with PCV followed by "boosting" with PPV in adults who had recovered from pneumococcal pneumonia...
  11. ncbi request reprint Treatment of Clostridium difficile-associated disease: old therapies and new strategies
    Saima Aslam
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Lancet Infect Dis 5:549-57. 2005
    ..Hospital infection control and pertinent use of antibiotics can limit the spread of CDAD. A vaccine directed against C difficile toxin may eventually offer a solution to the CDAD problem...
  12. ncbi request reprint Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine
    Daniel M Musher
    Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 191:1063-7. 2005
    ..Recurrent pneumococcal bacteremia in patients who have undergone splenectomy may indicate a genetically regulated failure to respond to PPV-23; PCPV-7 may stimulate production of IgG to PSs in such patients...
  13. doi request reprint Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study
    Daniel M Musher
    Infectious Disease Section, The Medical Care Line, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Clin Infect Dis 48:e41-6. 2009
    ..We report a prospective, double-blind, randomized controlled trial comparing nitazoxanide with vancomycin for treatment of CDI...
  14. doi request reprint Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA
    Daniel J Livorsi
    Section of Infectious Diseases, Baylor College of Medicine, One Baylor Plaza, BCM 286, N1319, Houston, TX 77030, USA
    J Infect 57:128-31. 2008
    ..aureus (MRSA) has complicated the treatment of this infection. Our objective was to evaluate therapeutic outcomes for S. aureus vertebral osteomyelitis in a setting of high MRSA prevalence...
  15. ncbi request reprint Nitazoxanide for the treatment of Clostridium difficile colitis
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Clin Infect Dis 43:421-7. 2006
    ..Nitazoxanide, a nitrothiazolide, blocks anaerobic metabolism of eukaryocyes and effectively treats intestinal infestation due to Cryptosporidium or Giardia species. At low concentrations, this compound inhibits C. difficile in vitro...
  16. doi request reprint The incidence of necrotizing changes in adults with pneumococcal pneumonia
    Anupam Pande
    School of Public Health, University of Texas Health Science Center, Houston, Texas, USA
    Clin Infect Dis 54:10-6. 2012
    ..We systematically studied the incidence of necrotizing changes in adult patients with pneumococcal pneumonia and examined the severity of infection, role of causative serotypes, and association with bacteremia...
  17. doi request reprint The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century
    Adriana M Rueda
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Medicine (Baltimore) 89:331-6. 2010
    ..The overall mortality at 30 days was 16% and was similar in vaccinated and nonvaccinated subjects. IPD causes a wide spectrum of disease. Mortality is substantial. PPV23 is clearly not fully protective...
  18. ncbi request reprint Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Medical Service, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 43:1004-8. 2006
    ..Despite the widespread acceptance of the 23-valent pneumococcal capsular polysaccharide vaccine (PPV), its protective effect continues to be disputed. We describe a novel approach to examine the protective effect of this vaccine...
  19. ncbi request reprint Clostridium difficile lacks detectable superantigen activity
    Anna Wanahita
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    FEMS Immunol Med Microbiol 47:275-7. 2006
    ..Elevated white blood cell counts in C. difficile colitis are probably due to increased generation of cytokines such as interleukin-6 (IL-6) or IL-8...
  20. doi request reprint Treatment of clostridium difficile colitis in the critical care setting
    Daniel M Musher
    Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030, USA
    Crit Care Clin 24:279-91, viii. 2008
    ..This article emphasizes treatment of Clostridium difficile colitis, considers diagnostic techniques, and describes means for preventing the spread of this infection in the intensive care setting...
  21. pmc V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons
    Jose A Serpa
    Department of Medicine, Infectious Diseases Section, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Vaccine Immunol 18:362-6. 2011
    ..Age or repeated immunization does not appear to affect the V(H)3-idiotypic immunogenicity of PPV among middle-aged and elderly adults...
  22. pmc A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection
    Hoonmo L Koo
    Baylor College of Medicine, University of Texas Houston School of Public Health, Houston, Texas, USA
    Clin Infect Dis 48:e75-7. 2009
    ..We describe here the unique challenges of the identification of NoVs as the true etiologic pathogen in an outbreak occurring in a health care setting, where C. difficile infection is endemic, as well as the important lessons learned...
  23. doi request reprint Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results
    Mark Parta
    Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Infect Control Hosp Epidemiol 31:1043-8. 2010
    ..To determine whether an earlier determination of staphylococcal species and their antibiotic susceptibility decreases unnecessary antistaphylococcal treatment and/or facilitates earlier appropriate treatment...
  24. pmc Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    J Clin Microbiol 45:2737-9. 2007
    ....
  25. ncbi request reprint Clinical significance of Staphylococcus aureus bacteriuria at a tertiary care hospital
    Mayar Al Mohajer
    Section of Infectious Diseases, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Scand J Infect Dis 45:688-95. 2013
    ..Staphylococcus aureus bacteriuria has been associated with invasive S. aureus disease. The current project describes the clinical significance of S. aureus bacteriuria...
  26. ncbi request reprint The impact of statin and macrolide use on early survival in patients with pneumococcal pneumonia
    Simit M Doshi
    University of Texas Health Science Center, Houston, TX, USA
    Am J Med Sci 345:173-7. 2013
    ..Statins and macrolides have broad immunosuppressive activity; their impact, separately and together, on survival in patients with pneumococcal pneumonia was evaluated...
  27. pmc In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations
    Samuel A Shelburne
    Section of Infectious Diseases 111G, Michael E DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030 4211, USA
    Antimicrob Agents Chemother 48:4016-9. 2004
    ..Community-associated MRSA were more likely to be synergistically inhibited by combinations of vancomycin and gentamicin versus vancomycin alone compared to inhibition associated with hospital-acquired strains...
  28. ncbi request reprint Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
    Daniel M Musher
    Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 40:1586-90. 2005
    ..In recent years, the rate of response to treatment with this drug has appeared to be much lower...
  29. doi request reprint Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin
    Praveena Marconescu
    Medical Care Line, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Scand J Infect Dis 44:620-2. 2012
    ..We found that killing by ceftaroline closely paralleled that of vancomycin. Telavancin killed bacteria significantly more slowly, whereas daptomycin killed significantly more rapidly...
  30. doi request reprint Bacteraemia from an unrecognized source (occult bacteraemia) occurring during Clostridium difficile infection
    Jimmy A Thomas
    Medical Care Line Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Scand J Infect Dis 43:269-74. 2011
    ..The purpose of this investigation was to determine if disruption of the colonic epithelium during Clostridium difficile infection (CDI) is associated with bacteraemia due to secondary bacterial invasion by enteric organisms...
  31. doi request reprint Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis
    Hoonmo L Koo
    Department of Medicine, Division of Infectious Diseases, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Infect Dis 48:598-605. 2009
    ..Further study of the role of antimotility agents in providing symptomatic relief and reducing environmental contamination with infectious stool may be warranted...
  32. doi request reprint Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia
    Adriana M Rueda
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Infect 60:99-105. 2010
    ....
  33. ncbi request reprint A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus
    Divay Chandra
    Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Chest 130:1942-6. 2006
  34. doi request reprint Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study
    Daniel M Musher
    Medical Care Line Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
    J Infect 67:11-8. 2013
    ..In this observational study, we systematically applied currently approved diagnostic techniques in patients hospitalized for CAP in order to determine the proportion in which an etiological agent could be identified...
  35. ncbi request reprint Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population
    Ingrid L Roig
    Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, BCM 286, N1319, Houston, TX 77030, USA
    Scand J Infect Dis 44:753-60. 2012
    ..We describe our experience of patients with IE, with particular attention to the role of pre-existing intravascular catheters and implanted cardiac devices in the pathogenesis...
  36. ncbi request reprint An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease
    Saima Aslam
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Room 4B 370, 2002 Holcombe Boulevard, Houston, TX 77030, USA
    Gastroenterol Clin North Am 35:315-35. 2006
    ..Biotherapy and vaccination are currently being explored as treatment options for patients who have recurrent disease. Greater attention should be paid to hospital infection control policies and restriction of broad-spectrum antibiotics...
  37. ncbi request reprint The association between pneumococcal pneumonia and acute cardiac events
    Daniel M Musher
    Medical Care Line, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 45:158-65. 2007
    ..We sought to determine the incidence of such events in patients who were hospitalized for community-acquired pneumococcal pneumonia...
  38. doi request reprint The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?
    Daniel M Musher
    The Medical Care Line Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas, USA
    Clin Infect Dis 52:633-40. 2011
    ..Unless an ongoing trial comparing 13-valent PCV with placebo (not to PPV) demonstrates a clearly better effect than that seen in the past with PPV, cost-effectiveness considerations are likely to prevent widespread use of PCV in adults...
  39. doi request reprint Clinical and microbiological end points in the treatment of pneumonia
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Clin Infect Dis 47:S207-9. 2008
    ..This brief contribution outlines areas for further consideration as new drugs are evaluated...
  40. doi request reprint Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 113:383-7. 2008
    ....
  41. doi request reprint Long-term survival following pneumococcal pneumonia
    Barcleigh Sandvall
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Infect Dis 56:1145-6. 2013
    ..Mortality was increased for up to 10 years after documented pneumococcal pneumonia and was greater in proportion to the PORT score at admission and among persons who had bacteremic disease...
  42. ncbi request reprint Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Medical Service, Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Infect Dis 39:165-9. 2004
    ..05). Microscopic examination of sputum samples before antibiotics were administered and performance of culture within 24 h of receipt of such treatment yielded the correct diagnosis in >80% of cases of pneumococcal pneumonia...
  43. doi request reprint IRIS iQ200 workstation as a screen for performing urine culture
    Mark Parta
    Medical Care Line Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Diagn Microbiol Infect Dis 75:5-8. 2013
    ..0% and 99.3% compared to ER. ASP did not enhance specificity, sensitivity, or NPV. The iQ200 Workstation performed well by any standard, thus providing a reliable system by which to improve the use of laboratory resources...
  44. doi request reprint Acute kidney injury associated with trimethoprim/sulfamethoxazole
    Traci Nicole Fraser
    Medical Care Line Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Antimicrob Chemother 67:1271-7. 2012
    ..We systematically studied the adverse renal effects of trimethoprim/sulfamethoxazole in a middle-aged veteran population...
  45. doi request reprint New modalities in treating pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Hosp Pract (1995) 39:89-96. 2011
    ..No clinical data favor the use of platelet-activating factor antagonists...
  46. ncbi request reprint Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent
    Saima Aslam
    Michael E DeBakey VA Medical Center, Section of Infectious Diseases, Room 4B 370, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Future Microbiol 2:583-90. 2007
    ..Further investigations regarding its use in patients with AIDS is needed. Nitazoxanide represents a significant advance in the treatment of intestinal parasitic infections worldwide...
  47. ncbi request reprint Clostridium difficile: recent epidemiologic findings and advances in therapy
    Nicole L McMaster-Baxter
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Pharmacotherapy 27:1029-39. 2007
    ..Rifaximin and PAR-101 are under investigation. Other therapies, including polymers that bind C. difficile toxin and monoclonal antibodies to toxins, and preventive measures such as toxoid vaccines are also under study...
  48. ncbi request reprint Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study
    Feng Yee Chang
    VA Medical Center, Infectious Disease Section, University Drive C, Pittsburgh, PA 15240, USA
    Medicine (Baltimore) 82:333-9. 2003
    ..Duration of antistaphylococcal therapy was not associated with relapse, but type of antibiotic therapy was. Nafcillin was superior to vancomycin in efficacy in patients with MSSA bacteremia...
  49. ncbi request reprint Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine
    Maria C Rodriguez-Barradas
    Baylor College of Medicine, Houston, Texas, USA
    Clin Infect Dis 37:438-47. 2003
    ..The immunogenicity of PV among patients receiving long-term HAART is modest. It seems best to immunize HIV-infected patients early in the course of disease...
  50. pmc Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis
    Daniel M Musher
    Medical Care Line Infectious Disease Section, Micheal E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Clin Microbiol 44:2304-6. 2006
    ..influenzae, biotype III. Infection progressed despite the presence of adequate serum bactericidal antibody, probably due to the absence of complement in ascites fluid...